Influence of liver disease staging on sustained virological response in HCV “Favourable” genotypes treated with PEG-interferon and ribavirin: Data from clinical practice

Risultato della ricerca: Articlepeer review

Lingua originaleUndefined/Unknown
pagine (da-a)S104-S105
RivistaDigestive and Liver Disease
Volume38, Supplement 1
Stato di pubblicazionePublished - 2006

Cita questo